The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(23)00816-2
Publication URI: http://dx.doi.org/10.1016/s1473-3099(23)00816-2
Type: Journal Article/Review
Parent Publication: The Lancet Infectious Diseases
Issue: 5